Latest:
Dr Beksac on OS Data From the OPTIMISMM Trial in Relapsed/Refractory Multiple Myeloma
Meral Beksac, MD, discusses overall survival data from the phase 3 OPTIMISMM trial in relapsed/refractory multiple myeloma.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Rona Yaeger, MD
Rona Yaeger, MD, is an associate attending physician, gastrointestinal medical oncologist, and early drug development specialist at the Memorial Sloan Kettering Cancer Center in New York.
Latest:
Dr Yaeger on the Efficacy of Adagrasib/Cetuximab in KRAS G12C+ mCRC
Rona Yaeger, MD, details the efficacy of adagrasib/cetuximab in heavily pretreated patients with KRAS G12C–mutant mCRC.
Rabi Upadhyay, MD
Rabi Upadhyay, MD, an instructor in the Department of Medicine at NYU Langone Health's Perlmutter Cancer Center
Latest:
Fellows on Film: What Makes a Good Mentor for an Oncology Fellow?
Michael L. Grossbard, MD, and Rabi Upadhyay, MD, Instructor, Department of Medicine at NYU Grossman School of Medicine, discuss the qualities that make someone a great mentor for an oncology fellow.
Yair Lotan, MD
Yair Lotan, MD, is a professor of urology, chief of Urologic Oncology, and holder of the Jane and John Juston Distinguished Chair in Urology, in Honor of Claus G. Roehrborn, MD, the University of Texas (UT) Southwestern Harold C. Simmons Comprehensive Cancer Center; as well as the medical director of the Urology Clinic at UT Southwestern and Parkland Health and Hospital System
Latest:
Dr Lotan on Guideline-Supported Treatment Decision-Making for NMIBC
Yair Lotan, MD, discusses guideline-supported treatment avenues for patients with BCG-unresponsive NMIBC.
Jasmine M. Zain, MD
Latest:
Dr. Jasmine Zain: Challenges in T-Cell Lymphoma Treatment
Jasmine Zain, MD, director of the T-cell Lymphoma Program, professor of hematology and hematopoietic stem cell transplantation, of City of Hope National Medical Center, discusses the challenges of treatment for patients with T-cell lymphoma.
Martha K. Terris, MD, FACS
Martha K. Terris, MD, FACS,is Professor and Chair of the Department of Urology, holding the Witherington Distinguished Chair in Urology at the Medical College of Georgia at Augusta University.
Latest:
Distinct Risk Factors for Bladder Cancer in Women Necessitate Diligent Early Detection Strategies: With Martha K. Terris, MD, FACS
Dr Terris discusses how the early diagnosis of bladder cancer presents a challenge, particularly in female patients, who are frequently diagnosed later.